Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
10/2003
10/09/2003CA2480869A1 Anxiolytic agents with reduced sedative and ataxic effects
10/09/2003CA2480857A1 Improvements in pharmaceutical compositions
10/09/2003CA2480679A1 (4,2-disubstituted-thiazol-5-yl)amine compounds as pde7 inhibitors
10/09/2003CA2480661A1 A method of modulating cellular activity
10/09/2003CA2480630A1 Tissue treatment
10/09/2003CA2480568A1 Thiazol-2-yl-imine compounds as pde-7 inhibitors
10/09/2003CA2480387A1 Use of lactobacillus farciminis for the prevention or pathology of digestive pathologies
10/09/2003CA2480372A1 Combination therapy using trefoil peptides
10/09/2003CA2480352A1 Lansoprazole polymorphs and processes for preparation thereof
10/09/2003CA2480317A1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
10/09/2003CA2479939A1 Immunosuppressant compounds, methods and uses related thereto
10/09/2003CA2479764A1 Hemiasterlin derivatives and uses thereof
10/09/2003CA2479744A1 Substituted 2,3-diphenyl pyridines
10/09/2003CA2479618A1 Spirocyclic amides as cannabinoid receptor modulators
10/09/2003CA2479205A1 Azaindoles as inhibitors of c-jun n-terminal kinases
10/09/2003CA2479110A1 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
10/09/2003CA2478918A1 Angiogenesis inhibitors
10/09/2003CA2478389A1 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/09/2003CA2477764A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003CA2448540A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/08/2003EP1350519A1 Drugs and foods improving the quality of life and process for producing the same
10/08/2003EP1350435A2 Compositions and methods for promoting lipid assimilation in pets
10/08/2003EP1350112A2 Methods for the treatment of ibs
10/08/2003EP1349930A2 Human proteins, polynucleotides encoding them and methods of using the same
10/08/2003EP1349927A2 Method for inhibiting the expression of a target gene and medicament for treating a tumor disease
10/08/2003EP1349873A2 Modulation of il-2- and il-15-mediated t cell responses
10/08/2003EP1349851A1 Compounds
10/08/2003EP1349850A1 Sodium channel modulators derived from 2-piperidylimidazoles
10/08/2003EP1349843A1 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors
10/08/2003EP1349841A2 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
10/08/2003EP1349840A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
10/08/2003EP1349839A1 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists
10/08/2003EP1349837A1 Antitumoral carbazoles
10/08/2003EP1349836A2 Tetracyclic derivatives as spla2 inhibitors
10/08/2003EP1349835A2 (+)-1-(3,4-dichlorophenyl)-3-azabicyclo 3.1.0]hexane, compositions and uses thereof
10/08/2003EP1349834A2 Cycloalkyfused [g]-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases
10/08/2003EP1349833A1 Indole and dihydroindole derivatives
10/08/2003EP1349832A2 Substituted benzoindoles as spla2 inhibitors
10/08/2003EP1349579A1 IMPROVED SOLUBILITY AND DISPERSIBILITY BY EXPOSURE TO O x?
10/08/2003EP1349562A2 Inhibiting gs-fdh to modulate no bioactivity
10/08/2003EP1349558A1 Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity
10/08/2003EP1349553A1 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain
10/08/2003EP1349548A2 Methods and compositions for treating periodontal disease
10/08/2003EP1349546A2 Dissociated glucocorticoid receptor antagonists for the treatment of clucocorticoid associated side-effect
10/08/2003EP1198464B1 8-PHENYL-6,9-DIHYDRO-[1,2,4]TRIAZOLO[3,4-i]PURIN-5-ONE DERIVATIVES
10/08/2003EP1181285B1 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
10/08/2003EP1140934B1 Benzisoxazoles and phenones as alpha-2-antagonists
10/08/2003EP0946512B1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
10/08/2003EP0927170B1 Piperazino derivatives as neurokinin antagonists
10/08/2003CN1447811A Medicinal compsns. and its use
10/08/2003CN1447804A 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders
10/08/2003CN1447694A Rapid onset formulation
10/08/2003CN1447692A Methods of drug delivergy to hepatocytes and treatment of flaviviridae infections
10/08/2003CN1447690A Inhibition of cystic fibrosis transmembrane conductance regulator chloride channel
10/08/2003CN1446813A Novel dihydric indole compound, their prepn. process and medicinal compsns. contg.them
10/08/2003CN1446578A Medicine efficacious for treating ulcer in the oral cavity and its production method
10/08/2003CN1446577A Medicine combination for treating child fastidium
10/08/2003CN1446555A Medicine for treating insufficiency of the kidney-yang syndrome and its preparing method
10/08/2003CN1446554A Medicine for treating acute cholecystitis and chronic cholecystitis and its preparing method
10/08/2003CN1446553A Medicine for treating chromic avidity, persistent hepatitis B and its preparation method
10/08/2003CN1446548A Medicine for treating gastric ulcer
10/08/2003CN1446539A Medicine for teating oral disease
10/08/2003CN1123566C Arylsulfonyl hydroxamic acid derivatives
10/08/2003CN1123356C Chinese medicine preparation for treating piles and its prepn. process
10/08/2003CN1123352C Cold eliminating pills
10/08/2003CN1123351C Externally applied liquid Chinese medicine for treating diarrhea
10/08/2003CN1123343C Nicotine compsns. and method for formulation thereof
10/08/2003CN1123338C Pharmaceutical formulation of omeprazole
10/08/2003CN1123337C Liquid aqueous pharmaceutical compsns. comprising sodium alginate and potassium bicarbonate
10/07/2003US6630512 Cell adhesion inhibitors
10/07/2003US6630505 Aminopyrrolidine sulfonamides as serine protease inhibitors
10/07/2003US6630503 Cell adhesion inhibitors
10/07/2003US6630492 Lymphocyte function antigen-1 antagonists
10/07/2003US6630485 For therapy of inflammatory disease
10/07/2003US6630483 Phenanthridine-N-oxides
10/07/2003US6630479 Methods and compositions utilizing quinazolinones
10/07/2003US6630477 Therapeutic nucleoside compound
10/07/2003US6630467 Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and their use in addiction therapy
10/07/2003US6630463 Heterocycle-containing carboxylic acid derivative and drug containing the same
10/07/2003US6630162 Pharmaceutical formulation and its use
10/07/2003CA2302436C Branched alkoxy-substituted 2-aminopyridines
10/07/2003CA2287552C Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
10/07/2003CA2263957C Diarylmethyl piperazine derivatives as delta opioid agonists
10/07/2003CA2261267C Gastroprotective flavone/flavanone compounds with therapeutic effect on inflammatory bowel disease
10/07/2003CA2207286C Localized delivery of factors enhancing survival of transplanted cells
10/02/2003WO2003081258A2 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs)
10/02/2003WO2003081238A2 Cytocapacity test
10/02/2003WO2003080673A1 Costimulatory molecule and its use
10/02/2003WO2003080626A1 Fused bicyclic pyridine derivative as tachykinin receptor antagonist
10/02/2003WO2003080625A1 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
10/02/2003WO2003080619A1 Fused bicyclic pyrimidine derivatives
10/02/2003WO2003080611A1 Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient
10/02/2003WO2003080610A1 Imidazopyridine derivatives as kinase inhibitors
10/02/2003WO2003080607A1 Novel alkoxypyridine-derivatives
10/02/2003WO2003080599A1 Stable hydrate of a muscarinic receptor antagonist
10/02/2003WO2003080594A1 Substituted chroman derivatives having cytochrome p450rai inhibitory activity
10/02/2003WO2003080581A1 Phenanthridinones as parp inhibitors
10/02/2003WO2003080579A1 Novel adamantane derivatives
10/02/2003WO2003080578A1 Heteroaromatic urea derivatives as vr-1 receptor modulators for treating pain
10/02/2003WO2003080568A2 Probucol derivatives
1 ... 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 ... 1258